Companies / Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd.

Nasdaq: QNRXCIK 1671502KFAR SABA

Financials · FY2021

Revenue$0
Net income$-15.80M
Total debt—
Cash$3.12M
Diluted EPS$-0.01
Shares outstanding72.3M

Ownership

72.3M shares outstanding · as of May 5, 2026
0.10%10%+ / strategic
Ownership
97.2%Common Stock
Share classes
Common Stock97.22%
Common Stock2.78%
10%+ / strategic0.10%75,000
Institutions1.09%789,800
Public float98.80%71,438,232

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Carter Denise P.Chief Operating Officer · Director
——
Cooper Joseph PatrickDirector
——
Culverwell Anthony JamesDirector
——
Langer DennisDirector
——
Lawlor Sally BridgetChief Financial Officer
——
Leong Natalie Ee MunDirector
——
Myers MichaelCEOChief Executive Officer · Director
——
Sember Michael TDirector
——
Stonepine Capital Management, LLC10% owner
——

Institutional holders 19

View all →
HolderValue% of shares
Ikarian Capital, LLC$3.05M0.29%
Woodline Partners LP$1.15M0.11%
Stonepine Capital Management, LLC$1.13M0.11%
Aberdeen Group plc$1.08M0.10%
SummitTX Capital, L.P.$935.0K0.09%
Boothbay Fund Management, LLC$863.5K0.08%
ADAR1 Capital Management, LLC$840.3K0.08%
Millennium Management LLC$503.2K0.11%
Resolute Capital Asset Partners LLC$432.9K0.04%
Soleus Capital Management, L.P.$360.8K0.03%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 4, 2026Culverwell Anthony James
Director
GrantShare Option (Right to Buy)—+22K
21,709
0.03% of shares
low
Feb 4, 2026Lawlor Sally Bridget
Executive
GrantShare Option (Right to Buy)—+85K
85,250
0.12% of shares
low
Feb 4, 2026Cooper Joseph Patrick
Director
GrantShare Option (Right to Buy)—+8K
8,141
0.01% of shares
low
Feb 4, 2026Myers Michael
CEO
GrantShare Option (Right to Buy)—+319K
318,750
0.44% of shares
low
Feb 4, 2026Carter Denise P.
Executive
GrantShare Option (Right to Buy)—+319K
318,750
0.44% of shares
low
Feb 4, 2026Langer Dennis
Director
GrantShare Option (Right to Buy)—+22K
21,709
0.03% of shares
low
Feb 4, 2026Sember Michael T
Director
GrantShare Option (Right to Buy)—+8K
8,141
0.01% of shares
low
Feb 4, 2026Leong Natalie Ee Mun
Director
GrantShare Option (Right to Buy)—+12K
12,211
0.02% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Integrated Core Strategies (US) LLCPassive13G/A———
Stonepine Capital Management, LLCPassive13G/A———
Ikarian Capital, LLCPassive13G/A———
Aberdeen Group plcPassive13G—75,000—
Woodline Partners LPPassive13G———
ADAR1 Capital Management, LLCPassive13G———
Integrated Core Strategies (US) LLCPassive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
QNRX——74907L409—